Active Immunization Study of Colon Cancer Derived 1-8D Peptide in HHD Mice
0
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Background: 1-8D gene is a member of human 1-8 interferon inducible gene family and was shown to be overexpressed in fresh colon cancer tissues. Three peptides 1-6, 3-5 and 3-7 derived from human 1-8D gene were shown to have immunogenicity against colon cancer. Methods: To study tumor immunotherapy of three peptides we established an active immunization model using HHD mice. Db / β2 microglobulin (β2 m) null mice transgenic for a chimeric HLA-A2.1/Db β2 m single chain (HHD mice) were challenged with B16/HHD/1-8D tumor cells and were immunized with irradiated peptide-loaded RMA- S/HHD/B7.1 transfectants. In therapy model tumor growth was retarded in HHD mice that were injected with 3-5 peptide-loaded RMA-S/HHD/B7.1. In survival test vaccination with 1-8D-derived peptide protects HHD mice from tumor progression after tumor challenge. Results: These studies show that peptide 3-5 derived from 1-8D gene can be the most effective candidate for the vaccine of immunotherapy against colon cancer and highlight 1-8D gene as putative colon carcinoma associated antigens. Conclusion: We demonstrated that RMA-S/HHD/ B7.1 loaded with 1-8D peptides, especially 3-5, immunization generates potent antitumor immunity against tumor cells in HHD mice and designed active immunization as proper immunotherapeutic protocols.
참고문헌 (22)
- "Clinical development of gene therapy for colorectal cancer", 3, pp.615~622 (2003)
- "Breast cancer associated antigen DF3", MUC-1 induces apoptosis of activated human T cells, 1999, 1367~1370
- "Gene expression profiles in normal and cancer cells", 276, pp.1268~1272 (1997)
- "1-restricted education and cytolytic activity of CD8 T lymphocytes from β2 microglobulin", 185, pp.2043~2051 (1997)
- "a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies", 29, pp.3112~3121 (1999)
- "Adoptive Transfer of Colon Cancer Derived Peptide-specific CD8 T Cells in HHD Mice", 4, pp.31~37 (2004)
- "Molecular analysis of a human interferon-inducible gene family", 199, pp.417~423 (1991)
- "Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method.", 25, pp.402~408 (2001)
- "-DNA-expressing vaccines induce in HLA-A2 1 transgenic mice stable cytotoxic T lymphocytes that target one major epitope", 34, pp.1206~1217 (2001), Inchauspe G
- "Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic", 10, pp.3064~3074 (2001)
- "Identification of HER-2", neu immunogenic epitopes presented by renal cell carcinoma and other human epithelial tumors, 2001, pp.11, 3261~3270
- "Characterization of novel breast carcinoma-associated BA46-derived peptides in HLA-A2", 110, pp.453~462 (2002)
- "Generation of CTL recognizing an HLA-A*0201-restricted epitope shared by MAGEA1 implication in a broad-spectrum tumor immunotherapy", 169, pp.575~580 (2002)
- "ALK as a novel lymphoma-associated tumor antigen identifi-cation of 2 HLA-A2", 99, pp.2100~2106 (2002)
- "HER-2", neu and hTERT cryptic epitopes as novel targets for broad spectrum tumor immunotherapy, 2002, pp.168(l 168), 5900~5906
- "Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity", 183, pp.283~287 (1996)
- "Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo", 183, pp.317~322 (1996)
- "Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity", 183, pp.7~11 (1996)
- "Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells", 4, pp.328~332 (1998)
- "Vaccination with mage-3A1 peptide-pulsed mature monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma", 190, pp.1669~1678 (1999)
- "Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma", 165, pp.2651~2656 (2000)
- "Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma model", 60, pp.6995~7001 (2000)